Lung adenocarcinoma as a solitary pulmonary nodule: Prognostic determinants of CT, PET, and histopathologic findings

被引:62
作者
Lee, Ho Yun [1 ,2 ]
Han, Joungho [3 ]
Lee, Kyung Soo [1 ,2 ]
Koo, Ji Hyun [1 ,2 ]
Jeong, Sun Young [1 ,2 ]
Kim, Byung-Tae [4 ]
Cho, Young-Seok [4 ]
Shim, Young Mog [5 ]
Kim, Jhingook [5 ]
Kim, Kwanmien [5 ]
Choi, Yong Soo [4 ,5 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul 135710, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul 135710, South Korea
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Nucl Med, Seoul 135710, South Korea
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul 135710, South Korea
关键词
Lung adenocarcinomas; Prognosis; Bronchioloalveolar carcinoma (BAC); component; Solitary pulmonary nodule (SPN); PET; CT; Ground-glass opacity (GGO); Tumor shadow disappearance rate (TDR); POSITRON-EMISSION-TOMOGRAPHY; VINORELBINE PLUS CISPLATIN; GROUND-GLASS OPACITY; HIGH-RESOLUTION CT; PERIPHERAL ADENOCARCINOMA; PREDICTS SURVIVAL; FDG-PET; CANCER; BRONCHIOLOALVEOLAR; IMPACT;
D O I
10.1016/j.lungcan.2009.02.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
We aimed to retrospectively compare CT, PET, and histopathologic (the extent of bronchioloalveolar carcinoma [BAC] components) findings of solitary pulmonary nodular (SPN) adenocarcinomas of the lung to determine their value as prognostic determinants. We reviewed CT and PET characteristics of tumors and pathologic specimens from 65 consecutive patients who underwent surgical resection for SPN adenocarcinomas. Nodule size and TDR (tumor shadow disappearance rate) were assessed from CT scans, and maximum standardized uptake value (SUVmax) of tumors was measured at PET. On pathologic examination, BAC, non-BAC, and central fibrous scar ratios were quantified. Prognosis was evaluated by noting disease recurrence during a minimum 12-month follow-up period after curative resection. The interrelationships between TDR, SUVmax, BAC, and non-BAC ratio were studied, and relationships between recurrence and various variables were analyzed. The median follow-up time was 33 months, and seven patients (11%) developed disease recurrence after surgical resection. TDR at CT and SUVmax at PET correlated well with pathologic BAC and non-BAC ratios. Between subgroups with and without recurrence, there were significant differences in SUVmax and BAC and non-BAC ratios. Based on univariate survival analyses, pathologic BAC and non-BAC ratios were risk factors significantly related to recurrence, but only high non-BAC ratio remained as an independent factor associated with recurrence in the multivariate analysis (hazard ratio [HR] = 0.956, P= 0.013). Among the factors examined, pathologic non-BAC ratio is the only independent risk factor for poor prognosis in patients with SPN adenocarcinomas. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:379 / 385
页数:7
相关论文
共 36 条
[1]
Ahuja V, 1998, CANCER, V83, P918, DOI 10.1002/(SICI)1097-0142(19980901)83:5<918::AID-CNCR17>3.3.CO
[2]
2-#
[3]
Peripheral lung adenocarcinoma: Correlation of thin-section CT findings with histologic prognostic factors and survival [J].
Aoki, T ;
Tomoda, Y ;
Watanabe, H ;
Nakata, H ;
Kasai, T ;
Hashimoto, H ;
Kodate, M ;
Osaki, T ;
Yasumoto, K .
RADIOLOGY, 2001, 220 (03) :803-809
[4]
The 2004 World Health Organization classification of lung tumors [J].
Beasley, MB ;
Brambilla, E ;
Travis, WD .
SEMINARS IN ROENTGENOLOGY, 2005, 40 (02) :90-97
[5]
Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC) -: A systematic review and meta-analysis (MA) by the European lung cancer working party for the IASLC lung cancer staging project [J].
Berghmans, Thierry ;
Dusart, Michele ;
Paesmans, Marianne ;
Hossein-Foucher, Claude ;
Buvat, Irene ;
Castaigne, Catherine ;
Scherpereel, Arnaud ;
Mascaux, Celine ;
Moreau, Michel ;
Roelandts, Martine ;
Alard, Stphane ;
Meert, Anne-Pascale ;
Patz, Edward F., Jr. ;
Lafitte, Jean-Jacques ;
Sculier, Jean-Paul .
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (01) :6-12
[6]
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging [J].
Cook, GJR ;
Wegner, EA ;
Fogelman, I .
SEMINARS IN NUCLEAR MEDICINE, 2004, 34 (02) :122-133
[7]
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]):: a randomised controlled trial [J].
Douillard, Jean-Yves ;
Rosell, Rafael ;
De Lena, Mario ;
Carpagnano, Francesco ;
Ramlau, Rodryg ;
Gonzales-Larriba, Jose Luis ;
Grodzki, Tornasz ;
Pereira, Jose Rodrigues ;
Le Groumellec, Alain ;
Lorusso, Vito ;
Clary, Claude ;
Torres, Antonio J. ;
Dahabreh, Jabrail ;
Souquet, Pierre-Jean ;
Astudillo, Julio ;
Fournel, Pierre ;
Artal-Cortes, Angel ;
Jassem, Jacek ;
Koubkova, Leona ;
His, Patricia ;
Riggi, Marcella ;
Hurteloup, Patrick .
LANCET ONCOLOGY, 2006, 7 (09) :719-727
[8]
Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection [J].
Downey, RJ ;
Akhurst, T ;
Gonen, M ;
Vincent, A ;
Bains, MS ;
Larson, S ;
Rusch, V .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3255-3260
[9]
Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer [J].
Hellwig, D ;
Gröschel, A ;
Graeter, TP ;
Hellwig, AP ;
Nestle, U ;
Schäfers, HJ ;
Sybrecht, GW ;
Kirsch, CM .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (01) :13-21
[10]
Higashi K, 1998, J NUCL MED, V39, P1016